Variables | Total participants | Non-hyperuricemia | Hyperuricemia | P |
---|---|---|---|---|
N, % | 1284 | 1080 (84.1) | 204 (15.9) | – |
Serum uric acid (μmol/l) | 311 ± 77 | 288 ± 57 | 431 ± 60 | < 0.0001 |
Visceral adiposity index | 2.17 (1.41–3.29) | 2.08 (1.31–3.08) | 2.84 (1.87–4.57) | < 0.0001 |
Fatty liver index | 37.9 (20.8–59.6) | 36.2 (19.5–58.1) | 48.4 (31.0–70.6) | < 0.0001 |
Lipid accumulation product | 47.7 (29.6–73.0) | 45.8 (27.9–68.2) | 62.8 (41.0–91.5) | < 0.0001 |
BMI (kg/m2) | 25.4 ± 3.5 | 25.2 ± 3.4 | 26.1 ± 3.7 | 0.001 |
Waist circumference (cm) | 89.8 ± 9.6 | 89.5 ± 9.6 | 91.4 ± 9.0 | 0.01 |
Neck circumference (cm) | 35.6 ± 3.5 | 35.5 ± 3.5 | 35.8 ± 3.5 | 0.22 |
Age (years) | 67.8 ± 8.6 | 67.4 ± 8.5 | 69.7 ± 8.7 | 0.0007 |
Male [n (%)] | 439 (34.2) | 384 (35.6) | 55 (27.0) | 0.018 |
Current smoker [n (%)] | 164 (12.8) | 144 (13.3) | 20 (9.8) | 0.17 |
Current drinker [n (%)] | 68 (5.3) | 58 (5.4) | 10 (4.9) | 0.78 |
High physical activity [n (%)] | 751 (58.5) | 637 (59.0) | 114 (55.9) | 0.41 |
SBP (mmHg) | 134 ± 15 | 134 ± 14 | 134 ± 15 | 0.98 |
DBP (mmHg) | 83 ± 9 | 83 ± 9 | 82 ± 9 | 0.04 |
TG (mmol/l) | 1.62 (1.19–2.23) | 1.57 (1.14–2.14) | 1.92 (1.44–2.86) | < 0.0001 |
TC (mmol/l) | 5.11 ± 0.98 | 5.11 ± 0.97 | 5.10 ± 1.06 | 0.91 |
LDL-c (mmol/l) | 2.70 ± 0.69 | 2.71 ± 0.69 | 2.69 ± 0.72 | 0.79 |
HDL-c (mmol/l) | 1.34 ± 0.30 | 1.36 ± 0.30 | 1.23 ± 0.26 | < 0.0001 |
FPG (mmol/l) | 5.60 (4.80–6.88) | 5.60 (4.80–6.95) | 5.58 (4.79–6.61) | 0.34 |
ALT (U/l) | 18.0 (14.0–25.0) | 18.0 (14.0–25.0) | 18.0 (14.0–25.0) | 0.56 |
AST (U/l) | 23.0 (19.0–27.0) | 22.1 (19.0–27.0) | 23.0 (19.0–28.4) | 0.23 |
GGT (U/l) | 21.0 (15.0–30.0) | 20.0 (15.0–29.0) | 23.0 (17.0–32.8) | 0.0029 |
eGFR (ml/min/1.73 m2) | 80.9 ± 14.2 | 82.8 ± 12.8 | 70.5 ± 16.5 | < 0.0001 |